An Autotransfusion Device Reduces the Amount of Allogenic Transfusion in Bilateral Sequential Total Knee Arthroplasty

Purpose: This study examined the difference in the reduction of the amount of required allogenic transfusion after bilateral total knee arthroplasty when an autotransfusion device was used. Materials and Methods: The subjects were ninety five patients who underwent sequential bilateral total knee arthroplasty from January 2006 to May 2010 by one surgeon. The first group was 50 patients who did not have an autotransfusion device used and second group of 45 patients were those who had an autotransfusion device used during the postoperative period. Group 1 received allogenic blood transfusion with a standard level of postoperative hemoglobin. The group 2 patients were reinfused with as much blood as was collected by an autotransfusion suction bag and then they received allogenic blood transfusion with a standard level of postoperative hemoglobin. Results: The total blood loss and amount of blood transfusion were almost the same in the two groups. The mean amount of allotransfusion was 1,270.0 mL in group 1 and 564.4 mL in group 2 and the reduced amount of allotransfusion in group 2 was statistically significant (p<0.05). Conclusion: Using an autotransfusion device is a good method to reduce the mean amount of allotransfusion after bilateral sequential total knee arthroplasty.

[1]  T. Sculco,et al.  Perioperative Morbidity in Bilateral One-Stage Total Knee Replacements , 2004, Clinical orthopaedics and related research.

[2]  T. Sculco,et al.  Blood Management After Bilateral Total Knee Arthroplasty , 2003, Clinical orthopaedics and related research.

[3]  H. Alter Discovery of non-A, non-B hepatitis and identification of its etiology. , 1999, The American journal of medicine.

[4]  J. Galante,et al.  An analysis of blood management in patients having a total hip or knee arthroplasty. , 1999, The Journal of bone and joint surgery. American volume.

[5]  M. Bould,et al.  Blood loss in sequential bilateral total knee arthroplasty. , 1998, The Journal of arthroplasty.

[6]  Andrew D. Rosenberg,et al.  Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy , 1996, Anesthesiology.

[7]  R. Spence Surgical red blood cell transfusion practice policies , 1995 .

[8]  D. Bae,et al.  Autotranfusion of the Autologous Shed Blood after Total Knee Replacement , 1995 .

[9]  R. Spence Surgical red blood cell transfusion practice policies. Blood Management Practice Guidelines Conference. , 1995, American Journal of Surgery.

[10]  T. Sculco,et al.  Salvage and reinfusion of postoperative sanguineous wound drainage. A preliminary report. , 1992, The Journal of bone and joint surgery. American volume.

[11]  P. Tartter,et al.  Postoperative infections following autologous and homologous blood transfusions , 1992, Transfusion.

[12]  Y. Kang,et al.  Prebanked Autologous Transfusion in Orthopedic Surgical Procedures , 1991 .

[13]  H. Jaffe,et al.  Transfusion-associated acquired immunodeficiency syndrome in the United States. , 1985, JAMA.

[14]  R. Weinstein,et al.  Acquired immunodeficiency syndrome (AIDS) associated with transfusions. , 1984, The New England journal of medicine.

[15]  T. Mallory Hypotensive anesthesia in total hip replacement. , 1973, JAMA.